BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 2919725)

  • 1. Kala azar with disseminated dermal leishmaniasis.
    Kumar PV; Sadeghi E; Torabi S
    Am J Trop Med Hyg; 1989 Feb; 40(2):150-3. PubMed ID: 2919725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucantime-resistant visceral leishmaniasis in immunocompromised patients.
    Verdejo J; Alvar J; Polo RM; González-Lahoz JM
    Am J Med; 1988 Jul; 85(1):128. PubMed ID: 3389377
    [No Abstract]   [Full Text] [Related]  

  • 3. Atypical disseminated leishmaniasis resembling post-kala-azar dermal leishmaniasis in an HIV-infected patient.
    Boumis E; Chinello P; Della Rocca C; Paglia MG; Proietti MF; Petrosillo N
    Int J STD AIDS; 2006 May; 17(5):351-3. PubMed ID: 16643688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Post-kala-azar dermal leishmaniasis associated with AIDS.
    Bittencourt A; Silva N; Straatmann A; Nunes VL; Follador I; Badaró R
    Braz J Infect Dis; 2002 Dec; 6(6):313-6. PubMed ID: 12585976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Kala-azar. Apropos of a case report in a Belgian woman].
    Coutellier P; Delgrange B
    Acta Clin Belg; 1989; 44(5):362-3. PubMed ID: 2609847
    [No Abstract]   [Full Text] [Related]  

  • 6. Visceral leishmaniasis without fever in an 11-month-old infant: a rare clinical feature of Kala-azar.
    Sayyahfar S; Ansari S; Mohebali M; Behnam B
    Korean J Parasitol; 2014 Apr; 52(2):189-91. PubMed ID: 24850963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of kala azar.
    Ozsoylu S
    Lancet; 1996 Jun; 347(9016):1701. PubMed ID: 8642997
    [No Abstract]   [Full Text] [Related]  

  • 8. Pseudo-acute transformation of an idiopathic myelofibrosis due to kala-azar.
    Disdier P; Swiader L; Serratrice J; Mary C; Weiller PJ
    Br J Haematol; 1998 Feb; 100(2):449. PubMed ID: 9488642
    [No Abstract]   [Full Text] [Related]  

  • 9. Low dose glucantime therapy in Leishmania viannia braziliensis (Lvb) infections.
    Costa JM; Marsden PD
    Rev Soc Bras Med Trop; 1988; 21(2):85-6. PubMed ID: 3249826
    [No Abstract]   [Full Text] [Related]  

  • 10. Severe leucopenia during treatment of visceral leishmaniasis.
    Hiçsönmez G; Jama H; Ozsoylu S
    Trans R Soc Trop Med Hyg; 1988; 82(3):417. PubMed ID: 3232176
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinico-epidemiological study of kala-azar in the south of Madrid].
    de la Serna FJ; Salto E; Valdés D; Vos Saus R
    Rev Sanid Hig Publica (Madr); 1987; 61(7-8):783-98. PubMed ID: 3438697
    [No Abstract]   [Full Text] [Related]  

  • 12. Visceral leishmaniasis with pericarditis in an HIV-infected patient.
    Mofredj A; Guerin JM; Leibinger F; Masmoudi R
    Scand J Infect Dis; 2002; 34(2):151-3. PubMed ID: 11928856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Historical series of patients with visceral leishmaniasis treated with meglumine antimoniate in a hospital for tropical diseases, Maceió-AL, Brazil.
    Silveira LJ; Rocha TJ; Ribeiro SA; Pedrosa CM
    Rev Inst Med Trop Sao Paulo; 2015; 57(1):33-8. PubMed ID: 25651324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Visceral and cutaneous leishmaniasis in an European paediatric population.
    Mattot M; Ninane J; Bigaignon G; Vermylen C; Cornu G
    Acta Clin Belg; 1992; 47(4):231-7. PubMed ID: 1329411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pediatric visceral leishmaniasis in Western Sicily, Italy: a retrospective analysis of 111 cases.
    Cascio A; Colomba C; Antinori S; Orobello M; Paterson D; Titone L
    Eur J Clin Microbiol Infect Dis; 2002 Apr; 21(4):277-82. PubMed ID: 12072938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Visceral leishmaniasis in a patient with human immunodeficiency virus.
    Rizzi M; Arici C; Bonaccorso C; Gavazzeni G
    Trans R Soc Trop Med Hyg; 1988; 82(4):565. PubMed ID: 3256108
    [No Abstract]   [Full Text] [Related]  

  • 17. Low dosage combination of meglumine antimoniate plus allopurinol as first choice treatment of infantile visceral leishmaniasis in Italy.
    di Martino L; Mantovani MP; Gradoni L; Gramiccia M; Guandalini S
    Trans R Soc Trop Med Hyg; 1990; 84(4):534-5. PubMed ID: 2091347
    [No Abstract]   [Full Text] [Related]  

  • 18. Visceral leishmaniasis in a Brazilian child infected perinatally with human immunodeficiency virus.
    Ferreira E; Lucena S; Fonseca G; Barbosa TC; Aquino RB; Lambert JS; Nogueira SA
    Pediatr Infect Dis J; 2001 Feb; 20(2):224-6. PubMed ID: 11224850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Visceral leishmaniasis during pregnancy treated with meglumine antimoniate.
    Utili R; Rambaldi A; Tripodi MF; Andreana A
    Infection; 1995; 23(3):182-3. PubMed ID: 7499009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The renal transplant patient with visceral leishmaniasis who could not tolerate meglumine antimoniate-cure with ketoconazole and allopurinol.
    Hueso M; Bover J; Serón D; Gil-Vernet S; Rufí G; Alsina J; Grinyó JM
    Nephrol Dial Transplant; 1999 Dec; 14(12):2941-3. PubMed ID: 10570102
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.